Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia.
Selvaggi P, Fazio L, Toro VD, Mucci A, Rocca P, Martinotti G, Cascino G, Siracusano A, Zeppegno P, Pergola G, Bertolino A, Blasi G, Galderisi S; Italian Network for Research on Psychosis. Selvaggi P, et al. Schizophr Res. 2023 Oct;260:76-84. doi: 10.1016/j.schres.2023.08.015. Epub 2023 Aug 24. Schizophr Res. 2023. PMID: 37633126 Free article.
DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine.
Gelao B, Fazio L, Selvaggi P, Di Giorgio A, Taurisano P, Quarto T, Romano R, Porcelli A, Mancini M, Masellis R, Ursini G, De Simeis G, Caforio G, Ferranti L, Lo Bianco L, Rampino A, Todarello O, Popolizio T, Blasi G, Bertolino A. Gelao B, et al. Among authors: selvaggi p. Psychopharmacology (Berl). 2014 Jun;231(11):2361-70. doi: 10.1007/s00213-013-3398-9. Epub 2014 Jan 15. Psychopharmacology (Berl). 2014. PMID: 24424781 Clinical Trial.
DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory.
Di Giorgio A, Smith RM, Fazio L, D'Ambrosio E, Gelao B, Tomasicchio A, Selvaggi P, Taurisano P, Quarto T, Masellis R, Rampino A, Caforio G, Popolizio T, Blasi G, Sadee W, Bertolino A. Di Giorgio A, et al. Among authors: selvaggi p. PLoS One. 2014 May 12;9(5):e95997. doi: 10.1371/journal.pone.0095997. eCollection 2014. PLoS One. 2014. PMID: 24819610 Free PMC article.
Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics.
Blasi G, Selvaggi P, Fazio L, Antonucci LA, Taurisano P, Masellis R, Romano R, Mancini M, Zhang F, Caforio G, Popolizio T, Apud J, Weinberger DR, Bertolino A. Blasi G, et al. Among authors: selvaggi p. Neuropsychopharmacology. 2015 Jun;40(7):1600-8. doi: 10.1038/npp.2015.5. Epub 2015 Jan 7. Neuropsychopharmacology. 2015. PMID: 25563748 Free PMC article.
Familial Risk and a Genome-Wide Supported DRD2 Variant for Schizophrenia Predict Lateral Prefrontal-Amygdala Effective Connectivity During Emotion Processing.
Quarto T, Paparella I, De Tullio D, Viscanti G, Fazio L, Taurisano P, Romano R, Rampino A, Masellis R, Popolizio T, Selvaggi P, Pergola G, Bertolino A, Blasi G. Quarto T, et al. Among authors: selvaggi p. Schizophr Bull. 2018 Jun 6;44(4):834-843. doi: 10.1093/schbul/sbx128. Schizophr Bull. 2018. PMID: 28981847 Free PMC article.
The Complex Interplay Between Physical Activity and Recovery Styles in Patients With Severe Mental Disorders in a Real-World Multicentric Study.
Sampogna G, Luciano M, Di Vincenzo M, Andriola I, D'Ambrosio E, Amore M, Serafini G, Rossi A, Carmassi C, Dell'Osso L, Di Lorenzo G, Siracusano A, Rossi R, Fiorillo A; Working Group LIFESTYLE. Sampogna G, et al. Front Psychiatry. 2022 Jul 11;13:945650. doi: 10.3389/fpsyt.2022.945650. eCollection 2022. Front Psychiatry. 2022. PMID: 35898630 Free PMC article.
Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium.
Constantinides C, Han LKM, Alloza C, Antonucci LA, Arango C, Ayesa-Arriola R, Banaj N, Bertolino A, Borgwardt S, Bruggemann J, Bustillo J, Bykhovski O, Calhoun V, Carr V, Catts S, Chung YC, Crespo-Facorro B, Díaz-Caneja CM, Donohoe G, Plessis SD, Edmond J, Ehrlich S, Emsley R, Eyler LT, Fuentes-Claramonte P, Georgiadis F, Green M, Guerrero-Pedraza A, Ha M, Hahn T, Henskens FA, Holleran L, Homan S, Homan P, Jahanshad N, Janssen J, Ji E, Kaiser S, Kaleda V, Kim M, Kim WS, Kirschner M, Kochunov P, Kwak YB, Kwon JS, Lebedeva I, Liu J, Mitchie P, Michielse S, Mothersill D, Mowry B, de la Foz VO, Pantelis C, Pergola G, Piras F, Pomarol-Clotet E, Preda A, Quidé Y, Rasser PE, Rootes-Murdy K, Salvador R, Sangiuliano M, Sarró S, Schall U, Schmidt A, Scott RJ, Selvaggi P, Sim K, Skoch A, Spalletta G, Spaniel F, Thomopoulos SI, Tomecek D, Tomyshev AS, Tordesillas-Gutiérrez D, van Amelsvoort T, Vázquez-Bourgon J, Vecchio D, Voineskos A, Weickert CS, Weickert T, Thompson PM, Schmaal L, van Erp TGM, Turner J, Cole JH; ENIGMA Schizophrenia Consortium; Dima D, Walton E. Constantinides C, et al. Among authors: selvaggi p. Mol Psychiatry. 2023 Mar;28(3):1201-1209. doi: 10.1038/s41380-022-01897-w. Epub 2022 Dec 9. Mol Psychiatry. 2023. PMID: 36494461 Free PMC article.
32 results